Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLB Ltd
SLB
|
+$461M |
| 2 |
Qualcomm
QCOM
|
+$450M |
| 3 |
Marriott International
MAR
|
+$341M |
| 4 |
TIF
Tiffany & Co.
TIF
|
+$283M |
| 5 |
NRG Energy
NRG
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$962M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$551M |
| 3 |
WFM
Whole Foods Market Inc
WFM
|
+$510M |
| 4 |
Goldman Sachs
GS
|
+$478M |
| 5 |
Estee Lauder
EL
|
+$329M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.96% |
| 2 | Consumer Discretionary | 14.17% |
| 3 | Communication Services | 11.56% |
| 4 | Technology | 11.12% |
| 5 | Energy | 10.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Icon
ICLR
$13.9B
| $10.2M | 0.01% |
217,381
-500,043
| -70% | -$21.6M |
|
477
PUT
Ionis Pharmaceuticals
IONS
$9.14B
| $9.82M | 0.01% |
285,000
| – | – |
|
478
Ultragenyx Pharmaceutical
RARE
$2.56B
| $9.79M | 0.01% |
218,161
-65,059
| -23% | -$2.68M |
|
|
PE
479
DELISTED
PARSLEY ENERGY INC
PE
| $9.65M | 0.01% |
+401,018
| New | +$9.56M |
|
480
G-III Apparel Group
GIII
$1.55B
| $9.51M | 0.01% |
232,998
+200,008
| +606% | +$7.55M |
|
|
PLG
481
Platinum Group Metals
PLG
$159M
| $8.77M | 0.01% |
73,661
| – | – |
|
482
NN Inc
NNBR
$261M
| $8.74M | 0.01% |
341,614
+253,985
| +290% | +$5.75M |
|
|
TTPH
483
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $8.73M | 0.01% |
32,357
-3,940
| -11% | -$846K |
|
484
Qualys
QLYS
$4.78B
| $8.31M | 0.01% |
323,777
+1,663
| +0.5% | +$37.8K |
|
|
ISBC
485
DELISTED
Investors Bancorp, Inc.
ISBC
| $7.75M | 0.01% |
+701,155
| New | +$7.48M |
|
|
MKTO
486
DELISTED
MARKETO INC COM STK (DE)
MKTO
| $7.38M | 0.01% |
253,803
+5,251
| +2% | +$143K |
|
487
iShares Russell 1000 Growth ETF
IWF
$119B
| $7.02M | 0.01% |
+308,612
| New | +$6.77M |
|
|
ANAC
488
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
| $6.87M | 0.01% |
387,568
| – | – |
|
489
Cognizant
CTSH
$23.8B
| $6.83M | 0.01% |
+139,665
| New | +$6.81M |
|
|
RALY
490
DELISTED
RALLY SOFTWARE DEV CORP
RALY
| $6.36M | 0.01% |
583,839
-472,222
| -45% | -$5.88M |
|
|
YOKU
491
DELISTED
YOUKU TUDOU INC.(CAYMAN ISLS)
YOKU
| $6.34M | 0.01% |
265,755
+21,805
| +9% | +$489K |
|
|
ASPX
492
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $6.13M | 0.01% |
275,278
-24,722
| -8% | -$541K |
|
493
Alaunos Therapeutics
TCRT
$4.64M
| $6.11M | 0.01% |
10,105
-1,146
| -10% | -$638K |
|
494
ExxonMobil
XOM
$634B
| $6.11M | 0.01% |
60,671
-400
| -0.7% | -$40.3K |
|
495
Omeros
OMER
$816M
| $6.09M | 0.01% |
350,000
| – | – |
|
496
Tempest Therapeutics
TPST
$13.9M
| $6.03M | 0.01% |
225
-18
| -7% | -$424K |
|
|
STAY
497
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $5.93M | 0.01% |
256,006
+7,455
| +3% | +$168K |
|
498
Kirby Corp
KEX
$7.77B
| $5.8M | 0.01% |
49,549
+940
| +2% | +$101K |
|
|
SUNE
499
DELISTED
SUNEDISON, INC COM
SUNE
| $5.77M | 0.01% |
255,151
+4,987
| +2% | +$96.9K |
|
|
AERI
500
DELISTED
Aerie Pharmaceuticals
AERI
| $5.73M | 0.01% |
231,387
-26,325
| -10% | -$456K |
|
Similar funds
Jennison Associates's Q2 2014 Portfolio in Review
As of Q2 2014, Jennison Associates held 796 positions worth $109B, up 4.1% from $105B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Jennison Associates's Q2 2014 filing shows 64 new, 297 increased, 319 reduced and 90 closed positions. Its largest new stake was Qualcomm: 5,657,444 shares worth $448M. The largest sale was Allergan Inc, an estimated $962M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2014 buy was Qualcomm: 5,657,444 shares worth $448M.
- Jennison Associates added most to SLB Ltd in Q2 2014, an estimated $461M increase.
- Jennison Associates's biggest Q2 2014 reduction was Allergan Inc, cutting an estimated $962M.
- Jennison Associates fully exited Estee Lauder in Q2 2014, selling an estimated $329M.
- Jennison Associates's ten largest holdings make up 19% of its $109B portfolio in Q2 2014.
- Jennison Associates opened 64 new positions and closed 90 in Q2 2014.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $109B.
Based on Jennison Associates's 13F filing for Q2 2014, filed 8 Aug 2014.